Phase II study of pre-irradiation chemotherapy for childhood intracranial ependymoma. Children's Cancer Group protocol 9942: A report from the Children's Oncology Group

Pediatric Blood and Cancer

Volumn 59, Issue 7, 2012, Pages 1183-1189

  Garvin, James H ^a   Selch, Michael T ^b   Holmes, Emi ^c   Berger, Mitchell S ^d   Finlay, Jonathan L ^e   Flannery, Ann ^f   Goldwein, Joel W ^g   Packer, Roger J ^h   Rorke Adams, Lucy B ⁱ   Shiminski Maher, Tania ^j   Sposto, Richard ^c,k   Stanley, Philip ^e   Tannous, Raymond ^l   Pollack, Ian F ^m  

^a Department of Medicine   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c CHILDREN S ONCOLOGY GROUP   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

^e CHILDREN S HOSPITAL LOS ANGELES   (United States)

^f SAINT LOUIS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^g HOSPITAL OF THE UNIVERSITY OF PENNSYLVANIA   (United States)

^h CHILDREN'S NATIONAL MEDICAL CENTER   (United States)

ⁱ CHILDREN S HOSPITAL OF PHILADELPHIA   (United States)

^j CHILDREN S HOSPITAL AT MONTEFIORE   (United States)

^k UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^l UNIVERSITY OF IOWA HOSPITALS AND CLINICS   (United States)

^m CHILDREN S HOSPITAL OF PITTSBURGH   (United States)

more..

Author keywords

Ependymoma; Pre irradiation chemotherapy

Indexed keywords

CISPLATIN; CYCLOPHOSPHAMIDE; ETOPOSIDE; VINCRISTINE;

ADOLESCENT; ADULT; ARTICLE; CANCER CHEMOTHERAPY; CANCER COMBINATION CHEMOTHERAPY; CANCER SURVIVAL; CHILD; CHILDHOOD CANCER; EPENDYMOMA; EVENT FREE SURVIVAL; FEMALE; HEARING; HUMAN; HYPOKALEMIA; HYPOMAGNESEMIA; MAJOR CLINICAL STUDY; MALE; MULTIPLE CYCLE TREATMENT; NEPHROTOXICITY; NEUROTOXICITY; OTOTOXICITY; OVERALL SURVIVAL; PERIPHERAL NEUROPATHY; PRESCHOOL CHILD; PRIORITY JOURNAL; SCHOOL CHILD; SIDE EFFECT; SURVIVAL RATE; SURVIVAL TIME; TREATMENT RESPONSE; TUMOR GROWTH;

ADOLESCENT; ADULT; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BRAIN NEOPLASMS; CHILD; CHILD, PRESCHOOL; DISEASE-FREE SURVIVAL; EPENDYMOMA; FEMALE; HUMANS; MALE; NEOADJUVANT THERAPY; SURVIVAL RATE; YOUNG ADULT;

EID: 84867360163     PISSN: 15455009     EISSN: 15455017     Source Type: Journal    
DOI: 10.1002/pbc.24274     Document Type: Article

References (33)

1. Gurney JG, Smith MA, Bunin GR. CNS and miscellaneous intracranial and intraspinal neoplasms. In: Ries LA, Smith MA, Gurney JG, et al., editors. Cancer incidence and survival among children and adolescents: United States SEER Program 1975-1995. NIH Pub No 99-4649. Chapter 3. Bethesda, MD: National Cancer Institute SEER Program; 1999. pp. 51-63.
2. Dohrman GJ, Farwell JR, Flannary JT. Ependymomas and ependymoblastomas in children. J Neurosurg 1976;45:273-283.
3. Rorke LB, Gilles FH, Davis RL, et al. Revision of the World Health Organization classification of brain tumors for childhood brain tumors. Cancer 1985;56:1869-1886.
4. Kleihues P, Burger PC, Scheithauer BW. Histological typing of tumours of the central nervous system. WHO Blue Book, 2nd edition. Berlin: Springer; 1993.
5. Horn B, Heideman R, Geyer R. et al. A multi-institutional retrospective study of intracranial ependymoma in children: Identification of risk factors. J Pediatr Hematol Oncol 1999;21:203-211.
6. Pollack IF, Gerszten PC, Martinez AJ. et al. Intracranial ependymomas of childhood: Long-term outcome and prognostic factors. Neurosurgery 1995;37:655-666.
7. Sutton LN, Goldwein J, Perilongo G, et al. Prognostic factors in childhood ependymomas. Pediatr Neurosurg 1990;16:57-65.
8. Bouffet E, Foreman N. Chemotherapy for intracranial ependymomas [review]. Childs Nerv Syst 1999;15:563-570.
9. Duffner PK, Horowitz ME, Krischer JP, et al. Postoperative chemotherapy and delayed radiation in children less than three years of age with malignant brain tumors. N Engl J Med 1993;328:1725-1731.
10. Kalbfleisch J, Prentice R. The statistical analysis of failure time data. New York: John Wiley and Sons; 1980.
11. Kovnar E, Kun L, Burger P, et al. and the Pediatric Oncology Group: Patterns of dissemination and recurrence in childhood ependymoma: Preliminary results of Pediatric Oncology Group Protocol 8532. Ann Neurol 1991;30:457.
12. Hukin J, Epstein F, Lefton D. et al. Treatment of intracranial ependymoma by surgery alone. Pediatr Neurosurg 1998;29:40-45.
13. Goldwein JW, Leahy JM, Packer RJ, et al. Intracranial ependymomas in children. Int J Radiat Oncol Biol Phys 1990;19:1497-1502.
14. Strother D, Kepner J, Constine LS, et al. Dose-intensive chemotherapy prolongs event-free survival for very young children with ependymoma. Results of Pediatric Oncology Group study 9233. Proc Am Soc Clin Oncol 2000;19:585.
15. Grill J, Le Deley MC, Gambarelli D, et al. Postoperative chemotherapy without irradiation for ependymoma in children under 5 years of age: A multicenter trial of the French Society of Pediatric Oncology. J Clin Oncol 2001;19:1288-1296.
16. Geyer JR, Zeltzer PM, Boyett JM, et al. Survival of infants with primitive neuroectodermal tumors and malignant ependymomas of the CNS treated with eight drugs in 1 day: A report from the Childrens Cancer Group. J Clin Oncol 1994;12:1607-1615.
17. Geyer JR, Sposto R, Jennings M, et al. Multiagent chemotherapy and deferred radiotherapy in infants with malignant brain tumors: A report from the Children's Cancer Group. J Clin Oncol 2005;23:7621-7631.
18. Grundy RG, Wilne SA, Weston CL, et al. Primary postoperative chemotherapy without radiotherapy for intracranial ependymoma in children: The UKCCSG/SIOP prospective study. Lancet Oncol 2007;8:696-705.
19. Massimino M, Gandola L, Barra S, et al. Infant ependymoma in a 10-year AIEOP (Associazione Italiana Ematologia Oncologia Pediatrica) experience with omitted or deferred radiotherapy. Int J Radiation Oncol Biol Phys 2011;80:807-814.
20. Evans AE, Anderson JR, Lefkowitz-Boudreaux IB, et al. Adjuvant chemotherapy of childhood posterior fossa ependymoma: Craniospinal irradiation with or without adjuvant CCNU, vincristine, and prednisone: A Childrens Cancer Group study. Med Pediatr Oncol 1996;27:8-14.
21. Robertson PL, Zeltzer PM, Boyett JM. et al. Survival and prognostic factors following radiation therapy and chemotherapy for ependymomas in children: A report of the Children's Cancer Group. J Neurosurg 1998;88:695-703.
22. Sexauer CL, Khan AB, Burger PC, et al. Cisplatin in recurrent pediatric brain tumors: A Pediatric Oncology Group Phase II study. Cancer 1985;56:1497-1501.
23. Gaynon P, Ettinger L, Baum E, et al. Carboplatin in childhood brain tumors: A Children's Cancer Group Phase II trial. Cancer 1990;66:2465-2469.
24. Miser J, Krailo M, Smithson W, et al. Treatment of children with recurrent brain tumors with ifosfamide (ifos), etoposide (VP-16), and mesna (M): Results of a Phase II trial. Proc Am Soc Clin Oncol 1989;8:44.
25. Grill J, Kalifa C, Doz F, et al. A high-dose busulfan thiotepa combination followed by autologous bone marrow transplantation in childhood recurrent ependymoma. A Phase II study. Pediatr Neurosurg 1996;25:7-12.
26. Mason WP, Goldman S, Yates AY, et al. Survival following intensive chemotherapy with bone marrow reconstitution for children with recurrent intracranial ependymoma-A report of the Children's Cancer Group. J Neuro-Oncol 1998;37:135-143.
27. Chiu JK, Woo SY, Ater J, et al. Intracranial ependymoma in children: analysis of prognostic factors. J Neuro-Oncol 1992;13:283-290.
28. Merchant TE, Mulhern RK, Krasin MJ. et al. Preliminary results from a Phase II trial of conformal radiation therapy and evaluation of radiation-related CNS effects for pediatric patients with localized ependymoma. J Clin Oncol 2004;22:3156-3162.
29. Merchant TE, Li C, Xiong X, et al. Conformal radiotherapy after surgery for pediatric ependymoma: A prospective study. Lancet Oncol 2009;10:258-266.
30. Foreman NK, Love S, Gill SS, et al. Second-look surgery for incompletely resected fourth ventricle ependymomas: Technical case report. Neurosurgery 1997;40:856-860.
31. Needle MN, Goldwein JW, Grass J, et al. Adjuvant chemotherapy for the treatment of intracranial ependymoma of childhood. Cancer 1997;80:341-347.
32. Shaw EG, Evans RG, Scheithauer BW, et al. Postoperative radiotherapy of intracranial ependymoma in pediatric patients. Int J Radiat Oncol Biol Phys 1987;13:1457-1462.
33. Goldwein JW, Glauser TA, Packer RJ, et al. Recurrent intracranial ependymomas in children: Survival, patterns of failure, and prognostic factors. Cancer 1990;66:557-563.